Park Avenue Securities LLC Has $1.78 Million Stock Holdings in STERIS plc $STE

Park Avenue Securities LLC increased its holdings in shares of STERIS plc (NYSE:STE) by 279.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 7,016 shares of the medical equipment provider’s stock after purchasing an additional 5,165 shares during the quarter. Park Avenue Securities LLC’s holdings in STERIS were worth $1,779,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of STE. Asset Management One Co. Ltd. raised its holdings in shares of STERIS by 5.4% during the third quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider’s stock worth $24,366,000 after acquiring an additional 5,072 shares during the period. Dimensional Fund Advisors LP lifted its position in STERIS by 9.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider’s stock valued at $257,157,000 after acquiring an additional 89,250 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in STERIS by 16.9% in the 3rd quarter. Allianz Asset Management GmbH now owns 93,905 shares of the medical equipment provider’s stock worth $23,236,000 after purchasing an additional 13,553 shares during the period. Elo Mutual Pension Insurance Co bought a new position in STERIS during the 3rd quarter worth about $2,480,000. Finally, Cerity Partners LLC increased its holdings in STERIS by 28.8% during the 3rd quarter. Cerity Partners LLC now owns 96,853 shares of the medical equipment provider’s stock worth $23,966,000 after purchasing an additional 21,656 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

STE has been the topic of several recent research reports. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 7th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $275.20.

STERIS Stock Performance

Shares of STE opened at $222.04 on Wednesday. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The firm has a fifty day simple moving average of $245.43 and a 200 day simple moving average of $249.32. The stock has a market capitalization of $21.78 billion, a price-to-earnings ratio of 30.97 and a beta of 1.05.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same quarter in the previous year, the firm posted $2.32 EPS. The firm’s revenue was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Research analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were given a dividend of $0.63 per share. The ex-dividend date of this dividend was Tuesday, February 17th. This represents a $2.52 annualized dividend and a yield of 1.1%. STERIS’s dividend payout ratio is 35.15%.

Insider Buying and Selling

In other STERIS news, Director Cynthia L. Feldmann sold 3,098 shares of the firm’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the transaction, the director directly owned 705 shares in the company, valued at $167,233.05. This trade represents a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.07% of the company’s stock.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.